@article{6a822dd8a1d3478ab45c3afc0826a775,
title = "The CD20-specific engineered toxin antibody MT-3724 exhibits lethal effects against mantle cell lymphoma",
author = "Shengjian Huang and Changying Jiang and Hui Zhang and Taylor Bell and Hui Guo and Yang Liu and Yixin Yao and Dongfeng Zeng and Makhdum Ahmed and Krystle Nomie and Leo Zhang and Michael Wang",
note = "Funding Information: We thank Drs. Lan Pham and Felipe Samaniego from MD Anderson Cancer Center and Dr. Jianguo Tao from Moffitt Cancer Center for providing us with MCL cell lines. We thank MD Anderson RPPA Core facility (funded by NCI #P30 CA16672, Dr. Peter Pisters) for generating the RPPA data. We also thank Molecular Templates and Pharmacyclics, an AbbVie Company, for providing MT-3724 and ibrutinib, respectively, for the studies. ABT-199 was commercially purchased. This work was also supported by the generous donations made to the MD Anderson Cancer Center Mantle Cell Lymphoma Program of Excellence.",
year = "2018",
month = mar,
day = "1",
doi = "10.1038/s41408-018-0066-7",
language = "English (US)",
volume = "8",
journal = "Blood cancer journal",
issn = "2044-5385",
publisher = "Nature Publishing Group",
number = "3",
}